The workshop, broadcasted using TalkPoint’s webcasting technology, will be held on February 27 and March 4 from 8 a.m. to 4 p.m. ET. During the workshop, The Office of Hematology and Oncology Products plans to explore the potential utility of MRD as a surrogate endpoint in acute lymphoblastic leukemia (ALL) (including the relapsed setting), chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).
To register for the webcast and for information on upcoming FDAAC.com events, please visit www.FDAAC.com.
TalkPoint is the industry leader in global communications technology, specializing in browser-based audio and video webcasting. Since 1998, TalkPoint's easy-to-use, Software-as-
About FDAAdvisoryCommittee.com (FDAAC.com)
FDAAC.com provides live video webcasts of FDA Advisory Committee meetings captured on location. These meetings cover an array of topics related to medicinal health including OTC, prescription and treatment devices. These meetings often result in rulings on clinical trials, final approval and bans of medications and treatment options. TalkPoint is the exclusive webcast provider for FDAAdvisoryCommittee.com.